Members area login

Username

Password

Remember

Please enter your email address

 

Please enter your membership ID

 
Follow Cephalalgia
Follow IHS
LATEST NEWS

About the IHS

 
  • David William Dodick 2015-2017  (USA)

    David W Dodick, MD, FRCP (C), FACP, is Professor of Neurology at the Mayo Clinic College of Medicine and a consultant in neurology at the Mayo Clinic, in Scottsdale, Arizona. He is the Director of the Headache Program and the Sports Neurology and Concussion Program at Mayo Clinic in Arizona. Dr Dodick is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology (ABPN). He also holds United Council for Neurologic Subspecialties certification in headache medicine and ABPN certification in vascular neurology.

    Dr Dodick has authored more than 350 peer-reviewed publications and authored/edited 10 books. He is the Chair of the Sports Concussion Conference Workgroup and the AAN Annual Sports Concussion Conference of the American Academy of Neurology and a member of the AAN’s Annual Meeting Committee. He is a member of the scientific committee of the International Migraine Trust. He is Chair of the International Headache Academy. He is on the editorial board of several journals including Lancet Neurology, Journal of Neurology, Neurosurgery and Psychiatry, Postgraduate Medicine, Headache, and Cephalalgia.

    He is the immediate Past-President of the International Headache Society, Past President of the American Headache Society, Chair of the American Migraine Foundation, Director of the US Academic Headache Consortium, and past-Editor-in-Chief of Cephalalgia.

    Disclosures
    Consulting: Acorda, Allergan, Amgen, Alder, Promius, eNeura, Eli Lilly & Company, Insys therapeutics, Autonomic Technologies, Teva, Xenon, Tonix, Trigemina, Boston Scientific, GBS, Colucid, Zosano, Laydenburg Thalmann, Biocentric, Biohaven, Magellan, Charleston Laboratories, Theranica.
    Royalties: Oxford University Press and Cambridge University Press (Book Royalty).
    Editorial/honoraria from UpToDate, Chameleon Communications, Medscape, WebMD, Academy for Continued Healthcare Learning, Haymarket Medical Education, Global Scientific Communications, HealthLogix,
    Academy for Continued Healthcare Learning, MeetingLogiX, Wiley Blackwell, Oxford University Press, Cambridge University Press. Stock/options: GBS/Nocira, Epien, Healint, and Mobile Health. Consulting use
    agreement: NAS. Board position: King-Devick Inc.

  • Alan M Rapoport 2013-2015  (USA)

    Alan Rapoport is a Clinical Professor of Neurology at The David Geffen School of Medicine at the University of California, Los Angeles, where he teaches medical students, neurology residents and fellows. He is also the founder and Director-Emeritus of The New England Center for Headache in Stamford, Connecticut.

    Board-certified in neurology and headache medicine, he has co-authored more than 250 articles, chapters, and posters on headache. He has lectured around the country and internationally to general physicians and headache specialists on all aspects of headache pathophysiology, diagnosis, and treatment and has appeared many times on national radio and television programs, such as Today and Good Morning America.
    Dr Rapoport is an editor of Headache, CNS Drugs, and Editor-in-Chief of Neurology Reviews, and he reviews for many peer-reviewed journals including Cephalalgia, Neurology, New England Journal of Medicine and Headache. He has co-authored nine books on headache for patients, physicians, and nurses with Drs Fred Sheftell and Stewart Tepper. The most recent book, released in 2008, is Conquering Daily Headache, published by BC Decker.

    He is Founder and Chairman of the Board of a non-profit health care company named ProMyHealth. It's goal is to bring medical experts to patients for free and to improve the efficiency and lower the cost of health care.
    Dr Rapoport has served on the Board of Directors of the American Headache Society and is the immediate past President of the Fairfield County Neurological Society, the Founding President of the Headache Cooperative of New England, Founding Director of the Headache Cooperative of the Pacific, and until June 2011 was the Chairman of the Education and Membership Committee of the International Headache Society.

    Disclosures
    Speakers Bureau for Depomed
    Consultant for Avanir, Depomed, Dr. Reddy's, Electrocore, Impax, Merck, Teva and Winston

  • Peter J Goadsby 2011-2013  (UK) Special Recognition Award

    Board liaison for Child and Adolescent committee and Cluster Headache group.

    Peter Goadsby obtained his basic medical degree and training at the University of New South Wales, Australia. His neurology training was done under the supervision of Professor James W Lance in Sydney. After post-doctoral work in New York with Don Reis at Cornell, with Jacques Seylaz at Universite VII, Paris, and post-graduate neurology training at Queen Square in London with the Professors C David Marsden, Andrew Lees, Anita Harding and W Ian McDonald, he returned to the University of New South Wales, and the Prince of Wales Hospital, Sydney as a consultant neurologist and was promoted to Associate Professor of Neurology.

    He was appointed a Wellcome Senior Research Fellow at the Institute of Neurology, University College London in 1995. He was Professor of Clinical Neurology and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is now Professor of Neurology in the Department of Neurology, University of California, San Francisco and remains Honorary Consultant Neurologist at the Hospital for Sick Children, Great Ormond St, London. His major research interests are in the basic mechanisms of head pain in both experimental settings and in the clinical context of headache management. The work of the Headache Group involves human imaging and electrophysiological studies in primary headache, as well as experimental studies of trigeminovascular nociception. The aim is to understand what parts of the brain drive and modulate headache syndromes, and how those might be modified by treatment.

  • Hans-Christoph Diener 2009-2011  (Germany) Special Recognition Award

    Hans-Christoph Diener, MD, PhD is Professor of Neurology, Chairman of the Department of Neurology and Director of the Essen Headache Centre at the University of Duisburg-Essen in Germany. He was President of the German Neurological Society, President of the European Headache Federation (EHF), and the International Headache Society and chairs the German Headache Consortium and the German Stroke Data Bank.

    Professor Diener received his medical degree and doctorate at the Albrecht-Ludwigs-Universität in Freiburg, and continued his training there in the Departments of Neurology, Psychiatry, Internal Medicine and Surgery. Prior to joining the University of Essen in 1989, he was an Associate Professor of Neurology at the Department of Neurology at the University of Tübingen. He was a visiting Professor at the Neurological Sciences Institute in Portland, Oregon in 1984 and 1985 and at the University of New South Wales in Sydney in 1987 and 1988.

    Professor Diener's special research interests focus on headache and stroke. He has investigated the mechanisms and management of medication-overuse headache, the prophylactic action of drugs in migraine, the relationship between plasma levels of prophylactic agents and their clinical efficacy, the role of visual evoked potentials in migraine, the mechanisms of action of migraine drugs, PET studies during migraine attacks, and animal models of migraine. Professor Diener performed major studies in the epidemiology of chronic headache supported by the German Ministry of Research and Education.

    Professor Diener has authored or co-authored 734 articles in peer reviewed journals (158 as first author, 13 in the NEJM), 241 invited reviews, and 306 book chapters, and served as the editor or author of 71 books. His h index is 77. He is the editor of Aktuelle Neurologie, Stroke News, Kopfschmerz News and Arzneimitteltherapie, deputy editor of Cephalalgia and serves on the editorial boards of Lancet Neurology, Cerebrovascular Diseases, Future Neurology, The International Journal of Clinical Practice, European Neurology, Reviews in Contemporary Pharmacotherapy and Journal of Clinical Investigation.

    Professor Diener has been the PI in more than 30 trials on the acute treatment and prophylaxis of headache disorders.

    Disclosures
    HCD received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Addex Pharma, Alder, Allergan, Almirall, Amgen, Autonomic Technology, AstraZeneca, Bayer Vital, Berlin Chemie, Böhringer Ingelheim, Bristol-Myers Squibb, Chordate, Coherex, CoLucid, Electrocore, GlaxoSmithKline, Grünenthal, Janssen-Cilag, Labrys Biologicals, Lilly, La Roche, 3M Medica , Medtronic, Menerini, Minster, MSD, Neuroscore, Novartis, Johnson & Johnson, Pierre Fabre, Pfizer, Schaper and Brümmer, Sanofi, St. Jude, Teva and Weber & Weber. Financial support for research projects was provided by Allergan, Almirall, AstraZeneca, Bayer, Electrocore, GSK, Janssen-Cilag, MSD and Pfizer. Headache research at the Department of Neurology in Essen is supported by the German Research Council (DFG), the German Ministry of Education and Research (BMBF) and the European Union. HCD has no ownership interest and does not own stocks of any pharmaceutical company. HCD serves on the editorial boards of Cephalalgia and Lancet Neurology. HCD chairs the Clinical Guidelines Committee of the German Society of Neurology.

  • Michael A Moskowitz 2007-2009  (USA)

    Michael A Moskowitz, MD, MSc (Hon), FAAN, FAHS is Professor of Neurology at Harvard Medical School and a Member of the Affiliate Faculty of the Harvard-MIT Division of Health Sciences & Technology. He is Board Certified (Neurology, Internal Medicine) and trained at Yale, and at the Harvard-Longwood Neurology Program, respectively followed by 7 years on the Massachusetts Institute of Technology faculty and 31 years at the Massachusetts General Hospital (MGH) in Boston. His research interests focus on translational mechanisms in migraine and stroke. His bibliography includes 505 scientific publications and 45,000 literature citations. Public URL: http://scholar.google.com/citations?user=kXGyzFMAAAAJ

    He is listed among the highly cited scientists in Neuroscience. He holds more than a dozen patents and is Director of Stroke and Neurovascular Regulation Laboratory at MGH. He trained more than 100 postdoctoral +6 PhD candidates. His laboratory is credited with discovering the sensory innervation to the circle of Willis (1981), its transmitter tachykinins (1983), and anti-migraine 'triptan' receptors expressed on meningeal afferents (1988-1994). His group is also recognized for demonstrating the importance of neurogenic vasodilation and protein leakage to migraine (1988), and for providing the most technically advanced demonstration of cortical spreading depression in human brain (2001). His laboratory recently provided the first experimental evidence linking cortical spreading depression to trigeminal activation (2002) and provided the first evidence showing that migraine prophylactic drugs suppress cortical spreading depression, as a coherent action (2006). Awards include the Zülch Prize from the Max Planck Society; Thomas Willis Award, American Stroke Association; Decade of the Brain Lecture, American Academy of Neurology; the Ottorino Rossi Award; Bristol-Myers Research Award in Pain and Neuroscience; Soriano Lecturer American Neurological Association among others. He served as Scientific Advisory Board, Chairman, Max-Planck-Institute, Cologne Germany (2000-2006) and for the Humboldt University Berlin Stroke Research Center (2007-2011), and was recently appointed to the LeDuq Foundation SAB. He served as President of the International Society for Cerebral Blood Flow and Metabolism (2001-2003), the President of the IHS, and Board of Directors of the AHS. He was the recipient of the William Silen Award, Harvard Medical School, Lifetime Achievement in Mentoring in 2007. Recently, he was appointed by the Secretary of Health to the Interagency Pain Research Coordinating Committee commissioned by the Institute of Medicine to evaluate pain research portfolios for all USA government agencies (2011-2014).

  • Fumihiko Sakai 2005-2007  (Japan)

    Fumihiko Sakai obtained his MD in 1969 at the Keio University in Japan. His neurology residency and fellowship was done under Professor Fumio Gotoh in Tokyo, the research on cerebral blood flow in migraine under the supervision of Professor John Stirling Meyer in Houston, USA. His PhD was obtained in 1981 at the Keio University for the study of neurotransmitters and migraine.

    He served as Professor and Chairman of Neurology at the Kitasato University from 1997. Since 2010 he is Professor and Director of the Saitama International Headache Center at the Saitama Neuropsychiatric Institute in Saitama, Japan. He received the 13th and 14th Harold G Wolff Awards, served as President of International Headache Society during 2005-2007 and was Chairman of IHC 2005 in Kyoto, Japan. He is presently President of the Japanese Headache Society.

  • Peer Tfelt-Hansen 2003-2005  (Denmark) Special Recognition Award
  • Michel D Ferrari 2001-2003  (Netherlands)

    Michel D Ferrari, MD, PhD, is Professor of Neurology and Chair of the Leiden Centre for Translational Neuroscience at Leiden University Medical Centre (LUMC).

    He received his MD in 1980, his specialty certificates in Neurology and Clinical Neurophysiology in 1985, and his Ph.D. on "Serotonin and Migraine" in 1992 cum laude from LUMC (supervisors Profs. GW Bruyn & PR Saxena). He was a Research Fellow at Baylor College of Medicine, Houston with Professor KMA Welch, and at Harvard Medical School with Professor MA Moskowitz.

    Michel Ferrari is a corresponding member of the American Neurological Association, Honorary Member of IHS and the Italian Headache Society, and has received numerous awards including the Arnold Friedman Distinguished Clinician Researcher (1995) and the Harold G Wolff (1997) Awards from the American Headache Society, the Migraine Trust (2002), the European Headache Federation (2006), and the IHS Special (2009) Lectures, and the three-annually Hartmann Muller Prize for Biomedical Research from the University of Zurich (2011). In 2005 the Dutch Neurological Association awarded him with the five-annually Winkler Medallion for Excellence in Neurological Research and in 2004 The Netherlands Organisation for Scientific Research (NWO) gave him the prestigious Vci Innovational Research Personal Incentive Schema Award and in 2009 the Spinoza Life Time Achievement Premium, the highest science prize in The Netherlands, also known as the Dutch Nobel prize.

    Michel Ferrari is the PI of several international consortia, including the FP6 EUROHEAD programme, in which nine European centres collaborate to decipher the molecular neurobiology of migraine. He serves on executive and scientific boards of many scientific organisations, is associate editor of Cephalalgia, Eur J Neurology and Headache Currents, and is a regular reviewer for many prestigious scientific journals. He has organised several congresses, including the 1997 IHS World Congress in Amsterdam, and has authored many books and over 425 peer-reviewed publications on the neurobiological, genetic, and clinical aspects of migraine, cluster headache syndromes, ataxia, and epilepsy. He ranks among the top three most cited scientists on 'Migraine and Other Vascular Headaches'. His paper on the first migraine gene (Cell 1996) is the highest cited paper in the field.

  • Jean Schoenen 1999-2001  (Belgium)

    Jean Schoenen, MD, PhD, gained his medical degree in 1972 from Liège University. For 2 years he was years an International Fogarty Fellow in the Departments of Neurology and Neuropathology of the Massachusetts General Hospital-Harvard Medical School where he obtained certificates in Clinical Neurophysiology and Neuropathology. He has been a board-certified neurologist since 1979 and holds doctoral and post-doctoral degrees from Liège University. He was Research Director of the National Fund for Scientific Research-Belgium and Clinical Professor in Neurology before taking over Full Professorship at Liège University in 1998. He is acting chairman of the Department of Biomedical and Preclinical Sciences at the Faculty of Medicine - Ulg.

    Jean Schoenen's Research has focused on headache and spinal cord anatomy and pathology. He is leading the Headache & Neuronal Regeneration Research Unit and Headache Clinic at Liège University. He has authored 869 publications among which 388 peer-reviewed articles (H index: 54 after 1996), 87 book chapters and four books. He is Associate Editor of Cephalalgia and Editor-in-chief of Acta Neurologica Belgica. He is a former President of the International Headache Society and of the Belgian Neurological Society. He is founding past president of the Belgian Brain Council.

  • Ninan T Mathew 1997-1999  (USA) Deceased

    Dr Ninan T Mathew is a familiar name in the field of headache worldwide. Dr Mathew was born in the beautiful state of Kerala, in south India, and received his undergraduate degree at the University of Madras in Tamil Nadu and his medical degree at Trivandrum Medical College, Kerala. His interest in neurology started in medical school. Post-graduate training in neurology followed at Christian Medical College, Vellore, India. He completed additional fellowship training in cerebrovascular disease and stroke at Baylor College of Medicine in Houston, where he subsequently served as a faculty member.

    His interest in headache started through research, measuring cerebral blood flow in migraine patients while at Baylor. Early on, he realised that headache was totally ignored and poorly understood by physicians, even though it was a common malady. In the 1970's, aetiology and treatment of headache was primitive and the patients suffered needlessly with overuse of pain medication. Comorbidities of migraine were not given appropriate importance.

    These factors led Dr Mathew to establish the Houston Headache Clinic in 1976, with outpatient and inpatient facilities for comprehensive care, which was the first headache specialty centre in Texas. In 1984, he started the Dallas Headache Clinic. For 35 years, Houston Headache Clinic remained a major referral and research centre for treating headache patients from around the world.

    Dr Mathew served in various national and international organisations related to headache and was a past president of the International Headache Society and the American Headache Society. He was a former chairman of the Headache Section for the American Academy of Neurology, which he helped to form. He also served as the chairman of the American Council for Headache Education.

    Dr Mathew was one of the founding members of the international research group on cluster headache and was chairman of the Fifth International Headache Congress held in Washington, DC , in 1991. In 1999, he chaired the Ninth International Headache Congress in Barcelona, Spain.

    Dr Mathew significantly contributed to medical literature, with more than 200 scientific publications to his credit, in leading journals such as JAMALancet Neurology, and Neurology. These include the first description of transformation of episodic migraine into chronic daily headache (transformed migraine or chronic migraine); clinical importance of medication overuse in determining the progression of chronic migraine; and the importance of detoxification. Dr Mathew strongly believed that the majority of chronic headaches are migraine variants and that medication overuse and comorbidities are important factors that perpetuate the process.

    He wrote book chapters for numerous leading textbooks and monographs dealing with headache and edited books on cluster headache and his Handbook of Headache, which he co-authored with Dr Randy Evans, covers modern advances in headache.  Dr Mathew was guest editor for several Neurologic Clinics and served as a member of the Editorial Board of Headache and Cephalalgia. He was a frequent reviewer for NeurologyHeadache,Cephalalgia, and The Lancet

    Dr Mathew was a fellow of the American Academy of Neurology and was on the faculty of the courses offered at the annual meeting of the Academy. He was an invited lecturer on headache in medical meetings and universities in the United States and abroad, giving lectures on chronic daily headache, drug-induced (analgesic rebound) headache, and cluster headache. He was featured in a 2002 headache cover story in Time Magazine and appeared on numerous radio and television programs for the National Migraine Foundation and the American Council for Headache Education.

    Dr Mathew trained a number of physicians from various countries who have done fellowships at the Houston Headache Clinic and participated in clinical trials of new medications for headache therapy and directed more than 100 such studies.

    Dr Mathew was the recipient of several American Headache Society Awards, including the 1976 Harold G. Wolff Lecture Award and the 1994 John R Graham Distinguished Clinician Award.

    In February 2012, he received a Lifetime Achievement Award from the Texas Neurological Society at its annual conference in Austin, Texas.

    In addition to his active career, Dr Mathew was involved with various cultural institutions. He was a founding member of the Indian Doctor's Club in Houston and served as its second president. He was president of the India Cultural Center also in Houston and was on the advisory board of the Asia Society Texas Center. He was a founding patron of the Hobby Center for the Performing Arts and the Asian Galleries of the Museum of Fine Arts, Houston.

  • M G Bousser 1995-1997  (France)

    Marie-Germaine Bousser is Professor of Neurology at Paris Diderot University in France and  former head of Neurology Department in Lariboisière Hospital in Paris.

    She has been one of the founding members of the European Stroke Conference (1990) and the President and founder of the French Stroke Society (1996-1998). She has also been  President of the French Headache Society (1995-1998) and of the International Headache Society (1995-1997).

    After a thesis devoted to the prevention of cerebral artery thrombosis in the rabbit by aspirin and prostaglandin E1, Professor Bousser's research  has been clinically orientated and has mainly dealt with vascular neurology and migraine about which  she wrote over 400 papers and 8 books , with the following six main topics of interest:  
    1- Stroke prevention : she was the principal investigator of  the French AICLA Study (1983) , the second ever trial to demonstrate the efficacy of aspirin in secondary  stroke prevention and she was member of executive committees of many stroke  prevention trials (CAPRIE, ECST, PROGRESS, AMADEUS, PERFORM...)
    2- CADASIL, which she identified in 1993 in a single French family in collaboration with her co-worker geneticist Pr E. Tournier-Lasserve , and which is now known to affect over 600 families worldwide. This has been a major breakthrough in the understanding of small arteries diseases of the brain and of vascular dementia.
    3- Cerebral venous thrombosis : based on a personal series of 450 patients, Pr Bousser has written many papers and a book on various aspects of CVT presentation , diagnosis and treatment.. She is one of the coordinators of the ISCVT registry.
    4- Migraine and stroke : her team showed that migraine with aura is a risk factor for cerebral infarction in young women, particularly if they smoke or use oral contraceptives.
    5- Cervical artery dissections: she wrote over 20 papers on dissections and showed for the first time a statistical association between migraine and dissections.
    6- Familial hemiplegic migraine : Her group demonstrated the first location (on chromosome 19) of one the FHM genes, found a second gene location (on chromosome 1) and studied the phenotype-genotype correlations associated with mutations in FHM1 gene

    To recognize her achievements in stroke research, Professor Bousser was awarded the 2008 Johann Jakob Wepfer Prize given by the European Stroke Conference.

  • Jes Olesen 1993-1995  (Denmark) Special Recognition Award

    Jes Olesen, MD, is Professor of Neurology at the University of Copenhagen and Co-director of the Danish Headache Centre in Glostrup, Denmark. He began his medical training at the University of Copenhagen in 1967 and undertook specialist education in neurology at major teaching hospitals in Copenhagen, the National Hospital, Queen Square, London, and Cornell Medical Center, New York. He completed his Danish thesis in 1974 and became a  Lecturer in Neurology at the University of Copenhagen in 1975. In 1985 he became Professor of Neurology at the university. He was Chairman of Neurology at the Gentofte Hospital from 1985-1993 and at Glostrup Hospital from 1993-2000. In 1999 he was a Visiting Professor at Harvard University, USA. In 2001 he founded the Danish Headache Center at Glostrup Hospital. He has been Chair of the Lundbeckfoundation Center for neurovascular signalling since 2006 and from 2009-2010 was a Visiting Professor at the University of California Los Angeles, USA.

    Jes Olesen was Associate Editor of Cephalalgia from 1980-1986 and Pain from 1986-1990. He has been on the Editorial Boards of Clinical Neuro­logy and Neurosurgery, Functional Neurology, Journal of Cerebrovascular Blood Flow and Metabolism, Acta Neurologica Scandinavica, Current Opinions in Neurology, European Neurology and the European Journal of Neurology.

    Jes Olesen has been President of the Danish Headache Society, the Scandinavian Migraine Society, the International Headache Society,  the Danish Stroke Association, Year of the Brain 1997 campaign, the European Federation of Neurological Societies (EFNS) and the European Brain Council (EBC).

    Jes Olesen is an honorary member of the Australian Headache Society, the German Headache Society, the Austrian Headache Society, the Austrian Neurological Society, the French Neurological Society, the Association of British Neurologists, the German Neurological Society, the Polish Neurological Society and a corresponding member of the American Neurological Association and the European Federation of Neurological Associations (EFNA).

    Throughout his career he has received several prestigious awards, including Harold G Wolff Award, Arnold P Friedman Distinguished Clinicians Award, Monrad Krohn Prize, John J Bonica Award, Steins Prize, Mångbergs Prize Umå University, Federigo Sicuteri Prize, IHS Cephalalgia Lecture Award, Mogens Fog Prize,  Niels A Lassen Prize,  Best paper on Headache, Ottorino Rossi Award, Keeler Hammer Award, lifetime headache achievement award, and the Great Nordic Research Prize.

    Jes Olesen has published over 400 papers in refereed journals and over 200 papers in books, congress proceedings etc. Has edited or written 33 books, of which 'Basic mechanisms of headache' and 'The headaches' first, second and third edition are internationally acknowledged reference volumes. Has initiated and supervised 16 defended doctoral dissertations and 25 PhD dissertations. Each year is an invited speaker at several international meeting and has organised 19 international congresses or symposia. Citations: 17211      H-Factor: 70

    His current main research interests are headache classification, epidemiology, genetic epidemiology and genetics, Regional brain blood flow, SPECT, transcranial Doppler, MRI and FMRI, signalling molecules in migraine and novel targets for drug development, localisation, function and role of signalling molecules in animal migraine models.

    Disclosures
    Consultant: Curatis, Alder; Research support: Curatis; Honoraria: Curatism, Alder
     

  • Federigo Sicuteri 1991-1993  (Italy) Deceased

    Born of Tuscan parents in Borgo San Lorenzo, a small town near Florence located in the marvellous pastoral landscape of Mugello, he graduated in Medicine with honours at Florence University.

    As a bright young clinician of the Institute of Internal Medicine of Florence University, directed by Professor Enrico Greppi, he started his University career. He found his lifework when in the early 1950s Professor Greppi decided to found a Headache Centre to help the multitude of headache sufferers that he usually called ‘orphan patients'. In 1954 Professor Sicuteri, when still young, became Director of the first active Headache Centre in Europe. In a few years his enthusiasm and ability attracted a small cluster of young coworkers to start the fascinating exploration into headache. A few years later Federigo Sicuteri and his group were known throughout the world for their contributions in the field of headaches; his interests included basic pathophysiology, clinical pharmacology and clinical research. He published many hundreds of papers in the most learned international journals. Serotonin in the central headache theory was the leif-motif of his research. What is the source of pain in migraine and other primary headaches? He gave a Copernican answer to this question: the origin of headaches is not peripheral but central and it is due to a deficiency of brain serotonin. Based on this concept, he considered therapeutic mechanisms of ergotamine and methysergide as serotonin agents in the central nervous system (long before the triptans).

    Professor Sicuteri organized in Florence the World Congresses ‘Headache 80' and ‘Florence Headache 87' that reflected the phases during which headache acquired a modern base and a multidisciplinary community capable of working to bring relief to patients.

    International highlights among his many honours include numerous awards: in particular the ‘Harold. G Wolff Award' and the ‘Enrico Greppi Award' which he won twice. He was on the editorial board of several learned international journals.

    He was at first a full Professor of Clinical Pharmacology and then of Internal Medicine, Chief of the Department of Clinical Pharmacology and Medical Pathology, and finally was honoured as Emeritus Professor of Internal Medicine of Florence University. He also held many prestigious positions: in 1976 he founded the Italian Headache Society for the Study of Headache, of which he was twice President and then Honorary President. He was also a member of the Steering Committee of the International Headache Society and became President of that Society in the years 1991-1993.

    I am proud to represent colleagues from around the world and the whole headache community to honour Professor Federigo Sicuteri, a headache medicine pioneer. Personally, and together with old and young Florentine team members, I thank him for giving me the opportunity to explore the complexity of headache patients and their needs.

    M Fanciullacci
    Cephalalgia 2004;12;1090

  • K M A Welch 1989-1991  (USA)

    On December 2, 2002, Dr K Michael Welch assumed the presidency of Rosalind Franklin University of Medicine and Science. Dr Welch is a neurologist and world-renowned researcher whose career has focused on the study of brain function and structure in cerebrovascular disease, stroke and migraine.

    Dr Welch earned his medical degree at the University of Bristol School of Medicine, United Kingdom and came to the United States in the early 1970s. He held several positions at Baylor College of Medicine (Houston, Texas) including Chief of Neurology at the Ben Taub Hospital before relocating to Michigan in 1981 to become the founding chair of the Department of Neurology at Henry Ford Hospital (HFH), now the Henry Ford Hospital and Health Sciences Center which, as vice president for Academic Affairs, he founded and was instrumental to negotiations that culminated in its academic affiliation with Case Western Reserve University.

    Also at HFH, Dr Welch was director of the NMR Research Center, the Principal Investigator of two NIH-funded centres for stroke and headache research, and the clinician responsible for the overall conduct of the NINDS tissue plasminogen study (the first to establish effectiveness of thrombolysis in acute stroke). He also became the Principal Investigator of the SPARCL trial, the first to establish statin treatment for secondary stroke prevention.

    In 1999 Dr Welch served as Vice Chancellor for Research at the University of Kansas Medical Center and President, Research Institute. He also established the Hoglund Brain Imaging Center at KU and initiated construction of a new sixty million dollar basic science building funded by the Kansas legislature.

    Dr Welch continues to serve NIH as chair of several oversight committees for clinical trials. He has served as Clinical Professor at the University of Michigan, Professor of Neurology at Case Western Reserve University, and as Adjunct Professor at Oakland University and the University of New Mexico.

    Since becoming President of Rosalind Franklin University in 2002, Dr Welch renamed the University and successfully implemented a full institutional assessment that launched a new mission and vision for the university, integrating the education of all health professions with the goal of enhanced delivery of health care into a model of interprofessional education. In 2012 Dr Welch established an Alliance for Health Sciences with DePaul University.

    In July 2006, Dr Welch received an honorary Doctorate of Medicine Degree from his alma mater, the University of Bristol.

  • James W Lance 1987-1989  (Australia) Special Recognition Award

    James (Jim) Lance completed his medical degree at the University of Sydney in 1950 and began his clinical work as a Resident Medical Officer at the Royal Prince Alfred Hospital. He took up a National Health and Medical Research Council (NHMRC) fellowship at the University of Sydney in 1952 and was awarded his MD in 1955. In 1954 Professor Lance travelled to London, UK, to train as a neurologist and accepted a position as assistant house physician at the National Hospital in Queen Square. Upon his return to Australia, he combined teaching and clinical practice with appointments as visiting lecturer at the University of Sydney, Superintendent at the Northcott Neurological Centre and Honorary Assistant Physician at Sydney Hospital and St Luke's Hospital.

    Jim Lance left Australia once again in 1960 to follow his passion for research work at the Massachusetts General Hospital in Boston, USA. He returned to Australia as the founder of the department of neurology in the newly established medical school at the University of New South Wales (UNSW), where he remained throughout his professional career starting as senior lecturer, then Associate ProfessorP professor of Neurology - Personal Chair, and finally as Emeritus Professor. To further his research, he continued his clinical practice at the Prince Henry and Prince of Wales Hospitals and was Chairman of the Department of Neurology and Foundation Director of the Institute of Neurological Sciences (INS).

  • Marcia Wilkinson 1985-1987  (UK) Deceased

    Marcia Wilkinson set up the Regional Neurological Unit at the Eastern Hospitial, London, a rehabilitation unit for the young disabled, many with severe head injuries from car accidents. Her work in the migraine field is similarly pioneering. She set up the first migraine clinic in the UK at the Elizabeth Garrett Anderson Hospital in 1963. She helped found an NHS migraine clinic at St Bartholomew's Hospital and, from1970 until her retirement in 1995, was Medical Director of the City of London Migraine Clinic, the first clinic in the world to see patients in acute migraine attacks.

    Never one to turn away a new experience, she took on the Editorship of Cephalalgia shortly after her 70th birthday with no previous experience of running a journal. During her 2 years as Editor-In-Chief subscriptions increased and the quality of the journal improved with a parallel rise in the impact factor.

    A firm believer in the role of women in medicine, Dr Wilkinson has supported many doctors throughout their careers and has had the dubious experience of being a patient of some of them in later years. Around the late 1940s she was one of the first registrars to be appointed at the London Hospital (now the Royal London). As the first woman to apply for the post, she became the centre of an intense debate on whether women would be suitable tutors for the male students and junior doctors. The discussion was lengthy and the late Lord Russell Brain - a man of few words - was asked for his opinion. He replied "Since when have our wives been unsuited to bringing up our children". She was duly appointed.

    Anne MacGregor

  • Eero Hokkanen 1983-1985  (Finland)

    Eero Hokkanen was born in Hämeenlinna Finland in 1931. He first enrolled to study law but soon changed into medicine, graduating from the University of Helsinki in 1958. Postgraduate studies and training in neurology took place at the Helsinki University Central Hospital as well as London University, Institute of Neurology (at Queen Square) in UK. In 1964 Professor Hokkanen finished his specialist degree (state examination in Finland) in neurology. He completed his PhD on neurology for the Doctorate in Medical Sciences in 1969. Later he completed degrees also in healthcare administration in 1979, neurogeriatrics (subspeciality of neurology) in 1984, as well as geriatrics (independent speciality) in 1985.

    Eero Hokkanen held senior positions in neurology at the Department of Neurology of the Helsinki University Central Hospital during 1965-1969. In 1970 he was elected Professor of Neurology and Head of the University Department of Neurology, University of Oulu, in northern Finland. There he stayed for 17 years during which he also acted as the Leading Chief Physician of the Oulu University Hospital from 1976-1981.

    In 1987 Professor Hokkanen was appointed as the Director of the Department of Hospital Care at the National Board of Health, an agency directly under the Ministry of Social Affairs and Health in Helsinki.  After this in 1991 Hokkanen started working as the Deputy Director General of the National Agency for Welfare and Health and the Director of its Welfare and Health Services Department and in 1992 he became the Deputy Director General at the Ministry of Social Affairs and Health (working especially for its Department for Social and Health Services). At the end of 1994 he retired.

    Professor Hokkanen´s research from 1964 onwards was first focused on neuromuscular diseases (thesis in 1969). Very soon the main focus became directed to the many problems of headaches and especially migraine and in 1969 he was the promoter in founding the Finnish Migraine Society in Helsinki. He attended the first Scandinavian meeting on migraine held in Copenhagen in 1969, and next year the Finnish Migraine Society became full member of the Scandinavian Migraine Society. In the Finnish Migraine Society he served as Secretary from 1970-1973 and Chairman from 1973-1994, and in the Scandinavian Migraine Society as board member from 1970-1994 and as President from 1975-1976, 1981-1983 and 199-1991. In June 1976 a very successful joint meeting of the Italian Headache Society (with F Sicuteri as President) and the Scandinavian Migraine Society (E Hokkanen as President) was arranged in Florence, Italy.

    Eero Hokkanen was also a very active member of the WFN Research Group on Migraine and Headache during the years 1984-1994. He became the Board Member of the new International Headache Society in 1982 and during its first Congress in Munich 1983 Professor Hokkanen was elected for the Presidency of IHS. He served as the President from 1983-1985 and as a member of  the Executive Committee from 1983-1987. During 1983-1985 the new Constitution of the International Headache Society was discussed, prepared, approved, and finally signed by the Eero Hokkanen as IHS President and the IHS General Secretary, Volker Pfaffenrath. During 1991-1993 he was also a Board Member of the new European Headache Federation. In 1997 Professor Hokkanen became an honorary member of IHS.

    Throughout his career Eero Hokkanen has also been active in the World Federation of Neurology (WFN). He was a member of the Council of National Delegates from 1975-1981, and a member of the Research Group of Migraine and Headaches from 1984-1994. He was also Chairman of the FN Nomination Committee during two consecutive 4-years periods, from 1989-1993 and 1993-1997. Following that he was elected as a member of the Steering Committee from 1998-2001.

    After having been appointed to work within the agencies of Ministry of Social Affairs and Health in 1987, Professor Hokkanen´s focus of interest broadened into national health problems. He became engaged in working in high positions of trust in numerous national and regional committees and working groups within healthcare and welfare in Finland, appointed by the State Council of Finland, various ministries and governmental central offices, various universities, etc. Even after his retirement, Professor Hokkanen continued his international activities, authorised by the Ministry of Social Affairs and Health, enhancing and co-ordinating the co-operation in science and technology within the field of health and welfare between Japan and Finland from 1989-1995, and between P.R. China and Finland from 1993-1998. Many of these projects involved questions concerning the health of aging populations, where Professor Hokkanen´s expertise in neurology and geriatrics proved valuable.

  • Dieter Soyka 1981-1983  (Germany) Deceased

    The foundation of IHS started with a scientific meeting in Kiel, Germany, in 1982, organised by Dieter Soyka. An international working group formed at that meeting founded IHS in London in September 1982 and elected Dieter Soyka as the first President. He remained President until the first International Headache Congress in Munich in September 1983 which he also organised. Without him, IHS would not be the unique international scientific society for headache research and headache treatment it is today.

    Dieter Soyka was born on 9 November 1929 in Berlin, Germany, where he grew up and went to school. He started his medical studies at the Humboldt University in Berlin in 1947 and moved to the Free University Berlin in 1951 where he received his MD in 1953. Dieter Soyka worked as a clinician in several hospitals in Berlin during 1954 to 1962. He became a specialist in neurology and psychiatry, and in 1962 moved to the University of Erlangen where he started his scientific career. In 1966, he received the venia legendi for neurology and psychiatry, and in 1972 he received a professorship at the University of Erlangen.
     
    In 1973, he became the first Chairman of the Department of Neurology at the Christian-Albrecht-University in Kiel after separating neurology from psychiatry. Untiringly he shaped the Department's development and, already at the start of his tenure, focused on widespread neurological disorders such as headaches as well as cerebrovascular disorders. Groups studying migraine and headaches were not established in Germany at that time. Dieter Soyka recognized the need to stimulate and encourage research in this area. From 1981 to 1982 he was Dean of the Faculty of Medicine at the University. He retired in 1995, but remained active until recently as editor of a scientific journal and reviewer of several papers.  
     
    Dieter Soyka organised several conferences and scientific publications in order to spread knowledge on headache and, in particular, on migraine. Even in his last years, he regularly attended meetings and congresses of the scientific societies for headache research. His advice and his knowledge were well received by the younger generation. Several of the students and fellows who were educated at his department are now working as worldwide well-known headache and pain researchers. His lectures at the University were always overcrowded, and he regularly received the students' award for the best Professor of the Faculty. Over his long career, Dieter Soyka wrote 11 scientific books and more than 250 scientific papers.
     
    Dieter Soyka not only co-founded IHS, he was also first President of the German Migraine and Headache Society (founded in 1979) and first President of the German Interdisciplinary Association for Pain Therapy. In both societies he became an Honorary Member after his active years as President. He was also the first representative of the Migraine and Headache Research Group in the World Federation of Neurology.
     
    Besides Dieter Soyka's intense activities for the improvement of headache research, he was also committed to improving patient care. Dieter Soyka founded the first interdisciplinary pain conference in Kiel in 1985. He saw the need for establishing a dedicated outpatient service for pain disorders and established the first headache clinic at a University Neurology Department.
     
    From the very beginning, he recognised that headache and pain treatment is an interdisciplinary challenge, requiring the involvement of several professional groups. In particular, he aimed to combine clinical neurological research, laboratory research, and psychological research to better understand headache mechanisms and improve headache treatment.

    Dieter Soyka died in Kiel, Germany, on 14 April 2012 at the age of 82 years.

    Peter J Goadsby, Stefan Evers, Andreas Straube, Hartmut Göbel

You need to be a member of the IHS to access this area of the website, please sign in to continue.

To find out more about membership types and how to join the IHS click onto the 'join' banner on the home page.

Close this box to continue.

Access to the Members Directory is restricted to Standard IHS members

Members Login

Your membership is currently shown as unpaid.

To renew your membership online click HERE.

Otherwise, please contact Carol Taylor to discuss your renewal.

This document is only available to members – please login.